Draft guideline on the requirements for combined vaccines and associations of immunological veterinary medicinal products (IVMPs) - Revision 1

Submitted by Anonymous (not verified) on 23 January 2026 - 8:50

Draft guideline on the requirements for combined vaccines and associations of immunological veterinary medicinal products (IVMPs) - Revision 1

Opinion/decision on a Paediatric investigation plan (PIP): Kengrexal, cangrelor (tetrasodium), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Surgical and medical procedures, PIP number: EMA/PE/00002390

Submitted by Anonymous (not verified) on 22 January 2026 - 15:53

Opinion/decision on a Paediatric investigation plan (PIP): Kengrexal, cangrelor (tetrasodium), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Surgical and medical procedures, PIP number: EMA/PE/0000239079

Human medicines European public assessment report (EPAR): Opatanol, olopatadine, Date of authorisation: 16/05/2002, Revision: 26, Status: Authorised

Submitted by Anonymous (not verified) on 22 January 2026 - 15:48

Human medicines European public assessment report (EPAR): Opatanol, olopatadine, Date of authorisation: 16/05/2002, Revision: 26, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness